-
Case-Resource Centre
-
CCK-8 Trial Feedback Form (Guilin Medical College)Details
-
CCK-8 Trial Feedback Form (Wuhan University People's Hospital)Details
-
CCK-8 Trial Feedback Form (School of Pharmacy, Lanzhou University)Details
-
CCK-8 Trial Feedback Form 2 (Zhejiang University of Traditional Chinese Medicine)Details
-
CCK-8 Trial Feedback Form (Tongji Medical College, Huazhong University of Science and Technology)Details
-
CCK-8 Trial Feedback Form (Shanghai University)Details
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands